Skip to main content
Clinical Trials/NCT02923973
NCT02923973
Unknown
Not Applicable

Transvaginal Ultrasound Cervical Length Screening in Singleton Pregnancy With Prior Spontaneous Preterm Birth

Federico II University2 sites in 1 country500 target enrollmentJune 1, 2018
ConditionsPreterm Birth

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Preterm Birth
Sponsor
Federico II University
Enrollment
500
Locations
2
Primary Endpoint
Preterm delivery
Last Updated
6 years ago

Overview

Brief Summary

Preterm birth (PTB) is the major cause of perinatal morbidity and mortality. Worldwide, about 15 million babies are born too soon every year, causing 1.1 million deaths, as well as short- and long-term disability in countless survivors. Few prognostic tests are available to predict PTB. A short transvaginal ultrasound cervical length (TVU CL) has been shown to be a good predictor of PTB.Different strategies have been adopted for prevention of PTB. The evidence supports the use of vaginal progesterone in singleton pregnancies with short cervix, while cervical cerclage seems to be beneficial only in the subgroup of singleton gestations with both prior spontaneous PTB and TVU CL ≤25mm, and not in singletons without prior PTB, nor in multiple gestations.

However, so far there are no level-1 data on the efficacy of TVU CL screening neither in low risk nor in high risk pregnancy Thus, the investigators aim to assess the efficacy of a policy of TVU CL screening in singleton pregnancy with prior spontaneous PTB

Registry
clinicaltrials.gov
Start Date
June 1, 2018
End Date
March 1, 2022
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Federico II University
Responsible Party
Principal Investigator
Principal Investigator

Gabriele Saccone

MD

Federico II University

Eligibility Criteria

Inclusion Criteria

  • 18-50 years of age
  • Singleton gestations
  • Women with prior spontaneous preterm birth, defined as spontaneous preterm delivery 16 0/7 - 36 6/7 weeks

Exclusion Criteria

  • multiple gestation
  • Ruptured membranes or fetal structural or chromosomal abnormality at the time of randomization
  • Ballooning of membranes outside the cervix into the vagina at the time of randomization
  • Labor or cerclage in situ at the time of randomization

Outcomes

Primary Outcomes

Preterm delivery

Time Frame: Less than 37 weeks gestation

Secondary Outcomes

  • Neonatal death(Between birth and 28 days of age)
  • Low birth weight(Time of delivery)
  • Composite adverse neonatal outcome(Between birth and 28 days of age)
  • Admission to neonatal intensive care unit(Between birth and 28 days of age)
  • Gestational age at delivery(Time of delivery)
  • preterm birth rates(Less than 24, 28, 34 weeks gestation)
  • Birth weight(Time of delivery)

Study Sites (2)

Loading locations...

Similar Trials